National Academies Press: OpenBook

The Children's Vaccine Initiative: Continuing Activities (1995)

Chapter: APPENDIX A: PROMISE AND PROBLEMS . . . (FINAL AGENDA, LIST OF SPEAKERS AND PARTICIPANTS)

« Previous: DISCUSSION SUMMARY
Suggested Citation:"APPENDIX A: PROMISE AND PROBLEMS . . . (FINAL AGENDA, LIST OF SPEAKERS AND PARTICIPANTS)." Institute of Medicine. 1995. The Children's Vaccine Initiative: Continuing Activities. Washington, DC: The National Academies Press. doi: 10.17226/9103.
×

Appendix A

Promise and Problems: Hib, Pneumococcal, and Meningococcal Vaccines in the Developing World

September 12–13, 1994

Foundry Building, Room 2004

1055 Thomas Jefferson Street, NW

Washington, D.C.

Room 2004

FINAL AGENDA

Day 1

8:30

Continental Breakfast

9:00

Welcome and Introduction

Caroline Hall, Steering Committee Chair

9:10

Overview

Floyd Denny, University of North Carolina

Suggested Citation:"APPENDIX A: PROMISE AND PROBLEMS . . . (FINAL AGENDA, LIST OF SPEAKERS AND PARTICIPANTS)." Institute of Medicine. 1995. The Children's Vaccine Initiative: Continuing Activities. Washington, DC: The National Academies Press. doi: 10.17226/9103.
×

9:30

Determining Vaccine Need

Moderator: Samuel Katz, Steering Committee Member

Epidemiologic Data Gaps and Their Relevance to Vaccine Studies

Mark Steinhoff, Johns Hopkins University

  • The Situation in Nigeria and the United Arab Emirates

    Catherine Oyejide, College of Medicine, Ibadan, Nigeria

  • Serotype Surprise: The Case of Haemophilus influenzae in Egypt

    Mona Assad, VACSERA, Cairo, Egypt

  • The Global Burden of N. menigitidis-Caused Meningitis

    Jay Wenger, Centers for Disease Control and Prevention

10:30

Break

10:45

Discussion

11:45

Lunch

12:45

Overcoming Technologic Barriers

Moderator: Emil Gotschlich, Rockefeller University

Pneumococcal Conjugate Vaccines: Status and Prospects

John La Montagne, National Institutes of Health

The Limits of Conjugate Technology

Philip Russell, Children’s Vaccine Initiative

The Common-Antigen Approach to Vaccine Development

David Briles, University of Alabama

1:30

Discussion

2:30

Break

2:45

A Meningococcal B Vaccine for Children

Wendell Zollinger, Walter Reed Army Institute of Research

Suggested Citation:"APPENDIX A: PROMISE AND PROBLEMS . . . (FINAL AGENDA, LIST OF SPEAKERS AND PARTICIPANTS)." Institute of Medicine. 1995. The Children's Vaccine Initiative: Continuing Activities. Washington, DC: The National Academies Press. doi: 10.17226/9103.
×
 

One Approach to Constructing a Meningococcal A/B/C Vaccine

Carl Frasch, Food and Drug Administration

3:15

Discussion

4:00

Break

4:15

Summary and Synthesis: Day 1

Moderators

4:45

Adjourn

Day 2

8:30

Continental Breakfast

9:00

Proving Vaccine Efficacy: The Challenge of Developing-Country Field Trials

Moderator: George Siber, Massachusetts Department of Health

Pneumonia Diagnostics: The Achilles Heel of ARI Epidemiology

Claire Broome, Centers for Disease Control and Prevention

The Case-Control Method and Other Alternative Design Strategies

Helena Makela, National Public Health Institute, Helsinki, Finland

Report of a Post-Licensure Hib Efficacy Trial in Chile

Myron Levine, University of Maryland

9:45

Discussion

10:45

Break

11:00

The Public-/Private-Sector Interface

Moderator: William Hubbard, Steering Committee Member

  • An Industry Perspective

    Peter Paradiso/Frank Malinoski, Lederle-Praxis Biologicals

Suggested Citation:"APPENDIX A: PROMISE AND PROBLEMS . . . (FINAL AGENDA, LIST OF SPEAKERS AND PARTICIPANTS)." Institute of Medicine. 1995. The Children's Vaccine Initiative: Continuing Activities. Washington, DC: The National Academies Press. doi: 10.17226/9103.
×
 
  • A Biotech Perspective

    Dale Spriggs, Virus Research Institute

  • A Government Perspective

    George Curlin, National Institutes of Health

11:45

Discussion

12:30

Lunch

1:15

Introducing an Effective Vaccine

Moderator: Donald Shepard, Brandeis University

The Cost-Effectiveness of ARI Vaccines

Benjamin Schwartz, Centers for Disease Control and Prevention

The Purchase and Cost of New EPI Vaccines

Maria Costales, Ministry of Health, Philippines

Financing the use of Conjugate Hib Vaccine in Brazil

Otavio Oliva, SIREVA, Rio de Janiero, Brazil

2:00

Break

2:15

Facilitating Vaccine Production Capability

George Siber, Massachusetts Department of Health

The Importance of Infrastructure and National Commitment:

Lessons from the Polio Experience

Ciro de Quadros, Steering Committee Member

2:45

Discussion

3:45

Break

4:00

Summary and Synthesis: Day 2

Moderators

4:30

Closing Comments

Caroline Hall, Steering Committee Chair

4:45

Adjourn

Suggested Citation:"APPENDIX A: PROMISE AND PROBLEMS . . . (FINAL AGENDA, LIST OF SPEAKERS AND PARTICIPANTS)." Institute of Medicine. 1995. The Children's Vaccine Initiative: Continuing Activities. Washington, DC: The National Academies Press. doi: 10.17226/9103.
×

WORKSHOP SPEAKERS

Mona Asaad, M.D., Acting Director, The Egyptian Organization for Biological and Vaccine Production (VACSERA)

David Briles, Ph.D., Professor, Division of Microbiology, University of Alabama at Birmingham, Birmingham, AL

Claire Broome, M.D., Associate Director for Science, Centers for Disease Control and Prevention, Atlanta, GA

Maria Otelia Costales, Officer in Charge, Maternal and Child Health Service, Department of Health, Manila, Philippines

George Curlin, M.D., Deputy Director, Division of Microbiology and Infectious Disease, National Institute of Allergy, and Infectious Diseases, National Institutes of Health, Bethesda, MD

Floyd Denny, M.D., Professor of Pediatrics, Division of Community Pediatrics, University of North Carolina, Chapel Hill, NC

Ciro de Quadros, M.D, M.P.H., (IOM Steering Committee Member) Senior Advisor on Immunization, Pan American Health Organization, Washington, DC

Carl Frasch, Ph.D., Chief, Bacterial Polysaccharides Laboratory Division of Bacterial Products, Food and Drug Administration, Rockville, MD

Emil C. Gotschlich, M.D., Professor and Head, Bacterial, Pathogenesis and Immunology Laboratory, Rockefeller University, New York, NY

Caroline Breese Hall, M.D. (IOM Steering Committee Chair) Professor of Pediatrics and Medicine in Infectious Disease, University of Rochester, Rochester, NY

William N. Hubbard, Jr., M.D. (IOM Steering Committee Member) Hickory Corners, MI

Samuel L. Katz, M.D. (IOM Steering Committee Member), Wilburt C. Davison Professor Department of Pediatrics, Duke University Medical Center, Durham, N.C.

John La Montagne, Ph.D., Director, Division of Microbiology and Infectious Disease, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD

Myron M. Levine, M.D., D.T.P.H., Professor and Director, Center for Vaccine Development, University of Maryland, Baltimore, MD

Helena Makela, M.D., Ph.D., Director, Division of Infectious Diseases, National Public Health Institute, Helsinki, Finland

Frank J. Malinoski, M.D., Ph.D., Director, Clinical Research, Lederle-Praxis Biologicals, West Henrietta, NY

Otavio P. de Oliva, M.D., M.P.H., Coordinator Regional do SIREVA, Rio de Janeiro, Brazil

Dr. Catherine Oyejide, Department of Public Health and Occupational Medicine, United Arab Emirates University, United Arab Emirates

Suggested Citation:"APPENDIX A: PROMISE AND PROBLEMS . . . (FINAL AGENDA, LIST OF SPEAKERS AND PARTICIPANTS)." Institute of Medicine. 1995. The Children's Vaccine Initiative: Continuing Activities. Washington, DC: The National Academies Press. doi: 10.17226/9103.
×

Peter Paradiso, Ph.D., Senior Director of Scientific Affairs, Lederle-Praxis Biologicals, West Henrietta, NY

Philip Russell, M.D., Special Advisor to the CVI, Center for Immunization Research, Johns Hopkins University, Baltimore, MD

Benjamin Schwartz, M.D., Chief, Childhood and Vaccine-Preventable Diseases, Epidemiology Section, Centers for Disease Control and Prevention, Atlanta, GA

Donald S. Shephard, Ph.D., Institute for Health Policy, Brandeis University, Waltham, MA

George Siber, M.D., Director, Biologics Laboratory, Massachusetts Department of Health, Jamaica Plain, MA

Dale Spriggs, Ph.D., Director, Clinical Research and Development, Virus Research Institute, Cambridge, MA

Mark Steinhoff, M.D., Associate Professor, Center for Immunization Research, Department of International Health, Johns Hopkins University, Baltimore, MD

Jay Wenger, M.D., Chief, Childhood and Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA

Wendell Zollinger, Ph.D., Research Biologist, Department of Bacterial Diseases, Walter Reed Army Institute of Research, Washington, DC

WORKSHOP PARTICIPANTS

Judith R. Bale, Ph.D., Program Officer, Board on Science and Technology for International Development, Washington, DC

Kenneth Bart, M.D., Associate Director for Medical and Scientific Affairs, Office of International Health, U.S. Public Health Service, Rockville, MD

Alfred Bartlett, M.D., M.P.H., Acting Chief, Child Survival Division, Office of Health and Nutrition, Agency for International Development, Washington, DC

Ruth Brenner, M.D., Senior Staff Fellow, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD

Robert Clay, M.P.H., Acting Deputy Director, Office of Health and Nutrition, Agency for International Development, Washington, DC

John Clemens, M.D., Chief, Epidemiology Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD

Jose Luis Di Fabio, Advisor on Vaccines, Pan American Health Organization, Washington, DC

Gerald W. Fischer, M.D., President, Virion, Rockville, MD

James Froeschle, M.D., Director, Clinical Research, Connaught Laboratories, Swiftwater, PA

Suggested Citation:"APPENDIX A: PROMISE AND PROBLEMS . . . (FINAL AGENDA, LIST OF SPEAKERS AND PARTICIPANTS)." Institute of Medicine. 1995. The Children's Vaccine Initiative: Continuing Activities. Washington, DC: The National Academies Press. doi: 10.17226/9103.
×

Joan Fusco, North American Vaccine Inc., Beltsville, MD

Bruce G. Gellin, M.D., Assistant Professor, Department of International Health, Johns Hopkins University School of Hygiene and Public Health, Baltimore, MD

Dan Granoff, M.D., Executive Director, Clinical Research, The Biocine Company, Emeryville, CA

William Hausdorff, Ph.D., Project Officer, Children’s Vaccine Initiative Project, Agency for International Development, Office of Health and Nutrition, Washington, DC

Carole Heilman, Ph.D., Chief, Respiratory Diseases Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD

Akira Homma, Ph.D., Regional Advisor on Biologics, Pan American Health Organization, Washington, DC

David L. Klein, Ph.D., Bacterial Respiratory Disease Program Officer, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD

Kaimi Lin, M.D., Medical Research Officer, National Institute of Child Health and Human Development, National Institutes of Health, Rockville, MD

Sharon Mates, Ph.D., President, North American Vaccine Inc., Beltsville, MD

Paul M. Mendelman, Merck Research Laboratories, West Point, PA

Molly Mort, Ph.D., AAAS Fellow, Office of Health and Nutrition, Agency for International Development, Washington, DC

Trudy Murphy, M.D., Associate Professor of Pediatrics, University of Texas, Southwestern Medical Center/Dallas, Dallas, TX

David Oot, M.P.H., Director, Office of Health and Nutrition, Agency for International Development, Washington, DC

Jan T. Poolman, M.D., Head, Laboratory of Vaccine Development and Immune Mechanisms, National Institute of Public Health and Environmental Protection, Bilthoven, The Netherlands

Regina Rabinovich, M.D., Assistant Director, Division of Microbiology and Infectious Disease, National Institute of Allergy and Infectious Diseases, Rockville, MD

Malla Rao, Visiting Scientist, National Institute of Child Health and Human Development, National Institutes of Health, Rockville, MD

Anthony Robbins, M.D., Office of the Assistant Secretary for Health, National Vaccine Program Office, Rockville, MD

John B. Robbins, M.D., Chief, Laboratory of Development and Molecular Immunology, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD

Murray Trostle, Dr.P.H., Public Health Advisor, Office of Health and Nutrition, Agency for International Development, Washington, DC

Suggested Citation:"APPENDIX A: PROMISE AND PROBLEMS . . . (FINAL AGENDA, LIST OF SPEAKERS AND PARTICIPANTS)." Institute of Medicine. 1995. The Children's Vaccine Initiative: Continuing Activities. Washington, DC: The National Academies Press. doi: 10.17226/9103.
×

Ronnie Waldman, M.D., M.P.H., Deputy Director/Technical, BASICS, Agency for International Development, Washington, DC

Joel I. Ward, M.D., Chief, Pediatric Infectious Diseases, Harbor-University of California/LA, Torrance, CA

Roy Widdus, Ph.D., Office of the Assistant Secretary for Health, National Vaccine Program Office, Rockville, MD

James Young, Ph.D., Vice President, Research and Development, MedImmune, Gaithersburg, MD

Paul Zeitz, D.O., M.P.H., Child Survival Fellow, Agency for International Development, Office of Health and Nutrition, Washington, DC

Beatrice Zurita, London School of Hygiene and Tropical Medicine, University of London, London, England

Staff

Greg Pearson, Project Director

Dee Sutton, Administrative Assistant

Suggested Citation:"APPENDIX A: PROMISE AND PROBLEMS . . . (FINAL AGENDA, LIST OF SPEAKERS AND PARTICIPANTS)." Institute of Medicine. 1995. The Children's Vaccine Initiative: Continuing Activities. Washington, DC: The National Academies Press. doi: 10.17226/9103.
×
Page 41
Suggested Citation:"APPENDIX A: PROMISE AND PROBLEMS . . . (FINAL AGENDA, LIST OF SPEAKERS AND PARTICIPANTS)." Institute of Medicine. 1995. The Children's Vaccine Initiative: Continuing Activities. Washington, DC: The National Academies Press. doi: 10.17226/9103.
×
Page 42
Suggested Citation:"APPENDIX A: PROMISE AND PROBLEMS . . . (FINAL AGENDA, LIST OF SPEAKERS AND PARTICIPANTS)." Institute of Medicine. 1995. The Children's Vaccine Initiative: Continuing Activities. Washington, DC: The National Academies Press. doi: 10.17226/9103.
×
Page 43
Suggested Citation:"APPENDIX A: PROMISE AND PROBLEMS . . . (FINAL AGENDA, LIST OF SPEAKERS AND PARTICIPANTS)." Institute of Medicine. 1995. The Children's Vaccine Initiative: Continuing Activities. Washington, DC: The National Academies Press. doi: 10.17226/9103.
×
Page 44
Suggested Citation:"APPENDIX A: PROMISE AND PROBLEMS . . . (FINAL AGENDA, LIST OF SPEAKERS AND PARTICIPANTS)." Institute of Medicine. 1995. The Children's Vaccine Initiative: Continuing Activities. Washington, DC: The National Academies Press. doi: 10.17226/9103.
×
Page 45
Suggested Citation:"APPENDIX A: PROMISE AND PROBLEMS . . . (FINAL AGENDA, LIST OF SPEAKERS AND PARTICIPANTS)." Institute of Medicine. 1995. The Children's Vaccine Initiative: Continuing Activities. Washington, DC: The National Academies Press. doi: 10.17226/9103.
×
Page 46
Suggested Citation:"APPENDIX A: PROMISE AND PROBLEMS . . . (FINAL AGENDA, LIST OF SPEAKERS AND PARTICIPANTS)." Institute of Medicine. 1995. The Children's Vaccine Initiative: Continuing Activities. Washington, DC: The National Academies Press. doi: 10.17226/9103.
×
Page 47
Suggested Citation:"APPENDIX A: PROMISE AND PROBLEMS . . . (FINAL AGENDA, LIST OF SPEAKERS AND PARTICIPANTS)." Institute of Medicine. 1995. The Children's Vaccine Initiative: Continuing Activities. Washington, DC: The National Academies Press. doi: 10.17226/9103.
×
Page 48
Next: APPENDIX B: INVOLVING THE U.S. PUBLIC AND PRIVATE SECTORS IN THE CVI . . . (FINAL AGENDA, LIST OF SPEAKERS AND PARTICIPANTS) »
The Children's Vaccine Initiative: Continuing Activities Get This Book
×
MyNAP members save 10% online.
Login or Register to save!
  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!